IE
NVO

Israel Englander’s Novo Nordisk NVO Stock Holding History

Israel Englander’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.2M Buy
1,464,300
+708,700
+94% +$30.4M 0.03% 703
2026
Q1 		$27.8M Sell
755,600
-1,110,200
-60% -$52.6M 0.01% 1284
2025
Q4 		$94.9M Buy
1,865,800
+6,100
+0.3% +$312K 0.04% 453
2025
Q3 		$103M Buy
1,859,700
+1,419,200
+322% +$83.1M 0.04% 432
2025
Q2 		$30.4M Buy
440,500
+153,800
+54% +$10.5M 0.01% 1184
2025
Q1 		$19.9M Buy
286,700
+246,600
+615% +$20.4M 0.01% 1523
2024
Q4 		$3.45M Sell
40,100
-350,400
-90% -$37.9M ﹤0.01% 3169
2024
Q3 		$46.5M Buy
390,500
+191,400
+96% +$25.5M 0.02% 869
2024
Q2 		$28.4M Buy
+199,100
New +$26.4M 0.01% 1200
2024
Q1 		– Sell
-10,000
Closed -$1.03M – 6503
2023
Q4 		$1.03M Hold
10,000
– – ﹤0.01% 4140
2023
Q3 		$909K Sell
10,000
-30,000
-75% -$2.64M ﹤0.01% 4249
2023
Q2 		$3.24M Buy
40,000
+25,400
+174% +$2.07M ﹤0.01% 3063
2023
Q1 		$1.16M Buy
+14,600
New +$1.04M ﹤0.01% 3950
2014
Q3 		– Sell
-13,600
Closed -$314K – 3910
2014
Q2 		$314K Buy
+13,600
New +$300K ﹤0.01% 2847

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Israel Englander's NVO Position: Q2 2026 in Review

Israel Englander increased its Novo Nordisk (NVO) stake by 45% in Q2 2026, buying an estimated $26.9M and bringing the position to 2,035,939 shares worth $97.6M. The position accounts for 0.04% of the portfolio, ranked #523.

Israel Englander first reported a position in NVO in Q2 2013 and has held it in 47 quarters since. The position peaked at $309M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Israel Englander held 2,035,939 shares of Novo Nordisk worth $97.6M as of Q2 2026.
  • Israel Englander bought 627,086 Novo Nordisk shares in Q2 2026, an estimated $26.9M.
  • Novo Nordisk made up 0.04% of Israel Englander's portfolio in Q2 2026, its #523 holding.
  • Israel Englander first reported a position in Novo Nordisk in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Novo Nordisk position peaked at $309M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.